• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Research Progress in Predicting Hepatocellular Carcinoma with Portal Vein Tumour Thrombus in the Era of Artificial Intelligence.人工智能时代门静脉癌栓预测肝细胞癌的研究进展
J Hepatocell Carcinoma. 2024 Jul 17;11:1429-1438. doi: 10.2147/JHC.S474922. eCollection 2024.
2
Mechanisms of portal vein tumour thrombus formation and development in patients with hepatocellular carcinoma.肝细胞癌患者门静脉癌栓形成和发展的机制。
J Cell Mol Med. 2023 Aug;27(15):2103-2111. doi: 10.1111/jcmm.17808. Epub 2023 Jun 22.
3
Identification of key molecules in the formation of portal vein tumor thrombus in hepatocellular carcinoma based on single cell transcriptomics and experiments.基于单细胞转录组学和实验鉴定肝细胞癌门静脉肿瘤血栓形成中的关键分子
Transl Cancer Res. 2024 Apr 30;13(4):1737-1761. doi: 10.21037/tcr-23-1589. Epub 2024 Apr 7.
4
A new and rare type of hepatocellular carcinoma: Survival and gene analysis of portal vein tumour thrombus-type hepatocellular carcinoma.一种新型罕见肝细胞癌:门静脉癌栓型肝细胞癌的生存情况及基因分析
Pathol Res Pract. 2023 Jan;241:154260. doi: 10.1016/j.prp.2022.154260. Epub 2022 Dec 9.
5
TIPS plus sequential systemic therapy of advanced HCC patients with tumour thrombus-related symptomatic portal hypertension.TIPS 联合序贯系统治疗伴肿瘤栓子相关症状性门静脉高压的晚期 HCC 患者。
Eur Radiol. 2022 Oct;32(10):6777-6787. doi: 10.1007/s00330-022-08705-7. Epub 2022 Apr 20.
6
Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 edition.《肝细胞癌合并门静脉癌栓多学科诊治中国专家共识(2016年版)》
Oncotarget. 2017 Jan 31;8(5):8867-8876. doi: 10.18632/oncotarget.12817.
7
Extent of portal vein tumour thrombosis in patients with hepatocellular carcinoma: The more, the worse?肝细胞癌患者门静脉癌栓的范围:越多,越差?
Liver Int. 2019 Feb;39(2):324-331. doi: 10.1111/liv.13988. Epub 2018 Nov 9.
8
Portal vein tumor thrombus in advanced hepatocellular carcinoma: A case report.晚期肝细胞癌门静脉瘤栓:一例报告。
Oncol Lett. 2015 Jun;9(6):2495-2498. doi: 10.3892/ol.2015.3115. Epub 2015 Apr 14.
9
Foxp3+ regulatory T cells and the formation of portal vein tumour thrombus in patients with hepatocellular carcinoma.Foxp3+ 调节性 T 细胞与肝癌患者门静脉癌栓的形成。
Can J Surg. 2011 Apr;54(2):89-94. doi: 10.1503/cjs.028009.
10
Nomogram predicting survival of hepatocellular carcinoma with portal vein tumour thrombus after curative resection.预测根治性切除术后伴有门静脉癌栓的肝细胞癌患者生存情况的列线图
ANZ J Surg. 2019 Jan;89(1-2):E20-E25. doi: 10.1111/ans.14708. Epub 2018 Aug 17.

引用本文的文献

1
Locoregional Therapies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.伴有门静脉癌栓的肝细胞癌的局部区域治疗
J Gastrointest Cancer. 2025 Jul 23;56(1):162. doi: 10.1007/s12029-025-01280-2.

本文引用的文献

1
Association of serum AFP trajectories and hepatocellular carcinoma outcomes after hepatic arterial infusion chemotherapy: A longitudinal, multicenter study.血清 AFP 轨迹与肝动脉灌注化疗后肝细胞癌结局的关系:一项纵向、多中心研究。
Cancer Med. 2024 Jun;13(11):e7319. doi: 10.1002/cam4.7319.
2
Prognostic Role of Basal Serum Alpha-Fetoprotein in Patients with Hepatocellular Carcinoma Suitable for Curative Treatment.适合根治性治疗的肝细胞癌患者基础血清甲胎蛋白的预后作用。
Medicina (Kaunas). 2024 Apr 24;60(5):692. doi: 10.3390/medicina60050692.
3
Advancements in hepatocellular carcinoma management: the role of 18F-FDG PET-CT in diagnosing portal vein tumor thrombosis.肝细胞癌治疗进展:18F-FDG PET-CT 在诊断门静脉癌栓中的作用。
Nucl Med Commun. 2024 Aug 1;45(8):651-657. doi: 10.1097/MNM.0000000000001863. Epub 2024 May 17.
4
A guide to artificial intelligence for cancer researchers.癌症研究人员的人工智能指南。
Nat Rev Cancer. 2024 Jun;24(6):427-441. doi: 10.1038/s41568-024-00694-7. Epub 2024 May 16.
5
Automated abdominal CT contrast phase detection using an interpretable and open-source artificial intelligence algorithm.使用可解释和开源人工智能算法进行自动腹部 CT 对比期检测。
Eur Radiol. 2024 Oct;34(10):6680-6687. doi: 10.1007/s00330-024-10769-6. Epub 2024 Apr 29.
6
Radiomic signatures associated with tumor immune heterogeneity predict survival in locally recurrent nasopharyngeal carcinoma.与肿瘤免疫异质性相关的放射组学特征可预测局部复发性鼻咽癌的生存情况。
J Natl Cancer Inst. 2024 Aug 1;116(8):1294-1302. doi: 10.1093/jnci/djae081.
7
Investigation of deep learning model for predicting immune checkpoint inhibitor treatment efficacy on contrast-enhanced computed tomography images of hepatocellular carcinoma.基于肝细胞癌增强 CT 图像的免疫检查点抑制剂治疗效果的深度学习模型预测研究。
Sci Rep. 2024 Mar 19;14(1):6576. doi: 10.1038/s41598-024-57078-y.
8
Hepatocellular carcinoma with macrovascular invasion: need a personalized medicine for this complicated event.伴有大血管侵犯的肝细胞癌:针对这一复杂情况需要个性化医疗。
Hepatobiliary Surg Nutr. 2024 Feb 1;13(1):188-190. doi: 10.21037/hbsn-23-653. Epub 2024 Jan 16.
9
Clinical application of spectral CT perfusion scanning in evaluating the blood supply source of portal vein tumor thrombus in hepatocellular carcinoma.光谱CT灌注扫描在评估肝细胞癌门静脉癌栓血供来源中的临床应用
Front Oncol. 2024 Jan 17;13:1348679. doi: 10.3389/fonc.2023.1348679. eCollection 2023.
10
Circulating tumor cells participate in the formation of microvascular invasion and impact on clinical outcomes in hepatocellular carcinoma.循环肿瘤细胞参与微血管侵犯的形成,并影响肝细胞癌的临床结局。
Front Genet. 2023 Nov 2;14:1265866. doi: 10.3389/fgene.2023.1265866. eCollection 2023.

人工智能时代门静脉癌栓预测肝细胞癌的研究进展

Research Progress in Predicting Hepatocellular Carcinoma with Portal Vein Tumour Thrombus in the Era of Artificial Intelligence.

作者信息

Li Yaduo, Fan Ningning, He Xu, Zhu Jianjun, Zhang Jie, Lu Ligong

机构信息

Medical Imaging Department, Zhuhai Clinical Medical College of Jinan University (Zhuhai People's Hospital), Zhuhai, People's Republic of China.

Department of Interventional Medicine, Guangzhou First People's Hospital, Guangzhou, People's Republic of China.

出版信息

J Hepatocell Carcinoma. 2024 Jul 17;11:1429-1438. doi: 10.2147/JHC.S474922. eCollection 2024.

DOI:10.2147/JHC.S474922
PMID:39050809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11268770/
Abstract

Hepatocellular Carcinoma (HCC) is a condition associated with significant morbidity and mortality. The presence of Portal Vein Tumour Thrombus (PVTT) typically signifies advanced disease stages and poor prognosis. Artificial intelligence (AI), particularly Machine Learning (ML) and Deep Learning (DL), has emerged as a promising tool for extracting quantitative data from medical images. AI is increasingly integrated into the imaging omics workflow and has become integral to various medical disciplines. This paper provides a comprehensive review of the mechanisms underlying the formation and progression of PVTT, as well as its impact on clinical management and prognosis. Additionally, it outlines the advancements in AI for predicting the diagnosis of HCC and the development of PVTT. The limitations of existing studies are critically evaluated, and potential future research directions in the realm of imaging for the diagnostic prediction of HCC and PVTT are discussed, with the ultimate goal of enhancing survival outcomes for PVTT patients.

摘要

肝细胞癌(HCC)是一种与高发病率和死亡率相关的疾病。门静脉肿瘤血栓(PVTT)的存在通常意味着疾病处于晚期且预后不良。人工智能(AI),特别是机器学习(ML)和深度学习(DL),已成为从医学图像中提取定量数据的一种有前途的工具。AI越来越多地融入成像组学工作流程,并已成为各个医学学科不可或缺的一部分。本文全面综述了PVTT形成和进展的潜在机制,以及其对临床管理和预后的影响。此外,还概述了AI在预测HCC诊断和PVTT发展方面的进展。对现有研究的局限性进行了批判性评估,并讨论了HCC和PVTT诊断预测成像领域未来潜在的研究方向,最终目标是提高PVTT患者的生存结果。